Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic, syndromic intellectual disability characterized by usually profound intellectual disability with absent speech, severe infantile hypotonia with decreased or absent reflexes, markedly slow motor development (with no progress beyond the ability to sit independently), early-onset epilepsy, strabismus and post-natal onset of progressive brain atrophy (incl. loss of brain volume, ex vacuo ventriculomegaly, dysgenesis of corpus callosum, white matter abnormalities ranging from non-specific changes to leukodystrophy). Swallowing difficulties, respiratory insufficiency, osteoporosis and variable craniofacial dysmorphisms (incl. plagio/brachicephaly, bitemporal narrowing, high-arched eyebrows, high nasal bridge, anteverted nares, high palate, tented upper lip) may constitute additional clinical features.
Features include always present findings: Generalized hypotonia, Thin corpus callosum, Overlapping toe, and Profound global developmental delay and others; and very common findings: Exaggerated cupid's bow, Brachycephaly, Narrow forehead, and Motor delay and others. 100 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 19 | Encephalopathy, Multifocal epileptiform discharges, Hydrocephalus |
Muscles | 11 | Generalized hypotonia, Joint contracture, Shrinkage of the cerebellum (cerebellar atrophy) |
Eyes | 6 | Cloudy or opaque cornea (corneal opacity), Strabismus, Cataract |
Arms and legs | 5 | Overlapping toe, Tapered finger, Limb muscle weakness |
Head and neck | 4 | Microcephaly, High palate, Tented upper lip vermilion |
Bones and joints | 4 | Joint contracture, Sideways curvature of the spine (scoliosis), Delayed skeletal maturation |
Pregnancy and birth | 2 | Fetal pyelectasis, Decreased fetal movement |
Digestive system | 2 | Gastrostomy tube feeding in infancy, Feeding difficulties |
Ears | 1 | Hearing loss (hearing impairment) |
Lungs and breathing | 1 | Difficulty breathing (respiratory insufficiency) |
Lab test results | 1 | Mildly elevated creatine kinase |
Heart and blood vessels | 1 | Right aortic arch |
Age of onset: before birth.
To date, at least 117 individuals have been identified [E Durham, personal observation] and 73 individuals have been reported in the literature with biallelic pathogenic variants in TBCK [, , , , , , , , , , , , , , , , , ]. The following description of the phenotypic features associated with this condition is based on these reports. Table 2. TBCK-Related Neurodevelopmental Disorder: Frequency of Select Features
Feature | % of Persons w/Feature | Comment |
|---|---|---|
Severe-to-profound developmental delay/ intellectual disability | 100% | — |
Severe hypotonia | 100% | — |
TBCK function has not been fully characterized.
Hypotonia, infantile, with psychomotor retardation and characteristic facies 3 is associated with mutations in the TBCK gene on chromosome 4.
The TBCK pathogenic variant has been proposed as a founder variant in individuals of Puerto Rican ancestry. Affected individuals who have biallelic pathogenic p.Arg126Ter variants tend to have a more severe progressive and neurodegenerative course, including chronic respiratory failure and tracheostomy dependency .
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
No consensus clinical diagnostic criteria for TBCK-related neurodevelopmental disorder (TBCK-NDD) have been published.
TBCK-NDD should be considered in probands with the following clinical, laboratory, and brain MRI findings and family history.
Clinical findings
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
Genetic disorders of interest in the differential diagnosis of TBCK-related neurodevelopmental disorder (TBCK-NDD) are listed in . Note: Most affected individuals exhibit some degree of developmental regression and/or neurologic decompensation in the setting of illness, which often raises clinical concerns for mitochondrial disorders, although the features of TBCK-NDD are not sufficient to suggest a specific monogenic mitochondrial disorder per se. Table 3. Genes of Interest in the Differential Diagnosis of TBCK-Related Neurodevelopmental Disorder
Gene(s) | Disorder | MOI | Features of Disorder |
|---|---|---|---|
NALCN | Infantile hypotonia w/psychomotor retardation characteristic facies-1 (OMIM 615419) | AR | Hypotonia; Severe DD/ID; Seizures; Peripheral motor neuropathy |
Genetic testing for TBCK is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for hypotonia, infantile, with psychomotor retardation and characteristic facies 3 has been reported in the published literature.
No approved treatments are currently available for hypotonia, infantile, with psychomotor retardation and characteristic facies 3. The disease remains an area of unmet medical need.
No clinical practice guidelines for TBCK-related neurodevelopmental disorder (TBCK-NDD) have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with TBCK-NDD, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 4.
TBCK-Related Neurodevelopmental Disorder: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
| Measurement of weight, length/height, head circumference | To assess for growth deficiency
| Assess for evidence of macroglossia abnormal head shape. | Consider referral to craniofacial clinic.
| Neurologic eval | • To incl brain MRI
Consider EEG if seizures are a concern.
If clinically suspected due to hyporeflexia, EMG/NCS may be considered.
If evidence of profound neuromuscular weakness, consider eval for nocturnal hypoventilation.
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
Consider eval for alternative communication device.
Neurobehavioral/
| Neuropsychiatric eval | For persons age 12 mos: screening for concerns incl sleep disturbances, ADHD, anxiety, /or findings suggestive of ASD
| O...
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
Anecdotally, some affected individuals have had adverse effects to bisphosphonate infusions for management of osteoporosis. The frequency and mechanism of this observation in the TBCK-NDD population remain unclear, so close monitoring is advised if bisphosphonates are clinically indicated [X Ortiz-Gonzalez, personal observation].
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
1 trial found
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. TBCK-Related Neurodevelopmental Disorder: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Ophthalmologic involvement | Ophthalmology eval | At least annually, or as recommended by ophthalmologist |
Genitourinary | Monitor for signs/symptoms of urinary tract infections, neurogenic bladder, nephrolithiasis. | As needed |
Dyslipidemia | Complete lipid panel1 | Every 1-2 yrs |
Cardiovascular | Consider echocardiogram to monitor for left ventricular hypertrophy | Every 1-2 yrs (starting in adolescence or earlier if symptomatic) |
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
Phenotype severity distribution: 25 always present features, 5 very common features, 29 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for hypotonia, infantile, with psychomotor retardation and characteristic facies 3. Kisho has analyzed 3 by research type. Research spans Diagnostic / Biomarker (67%) and Case Report / Case Series (33%).
Osman N (2025). [PMID: 40524706](https://pubmed.ncbi.nlm.nih.gov/40524706/). *AJOG Glob Rep*. [Diagnostic / Biomarker]
Lewis RG (2025). [PMID: 41239373](https://pubmed.ncbi.nlm.nih.gov/41239373/). *BMC Med Genomics*. [Diagnostic / Biomarker]
Mastromoro G (2025). [PMID: 39865381](https://pubmed.ncbi.nlm.nih.gov/39865381/). *Am J Med Genet A*. [Case Report / Case Series]
Data assembled from 8 of 12 sources · Last updated Sep 20, 2026, 4:39 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Macroglossia
Up to 90% by age 10 yrs |
Progressive w/age |
Eye anomalies | 90% | — |
Cardiovascular | 86.6% w/dyslipidemia | Dyslipidemia typically involves hypercholesterolemia /or hypertriglyceridemia |
There are a few reports of congenital cardiac structural defects (10 affected persons reported) Aberrant head shape /or size | 85.7% | Incl 3/22 (14%) w/microcephaly, 7/22 (32%) w/macrocephaly, 5/22 (23%) w/brachycephaly, 3/22 (14%) w/turricephaly |
Respiratory insufficiency/failure | 84% | Can be progressive; congenital in fewer than 10% |
Osteopenia | 84% | Which may predispose to bony fractures |
Seizures | 76.7% | Onset usually between age 0-3 yrs |
Genitourinary findings | 60% by age 15 yrs | Typically recurrent urinary tract infections /or nephrolithiasis; renal anomalies not common Developmental delay (DD) and intellectual disability (ID). Gross and fine motor delays are often severe, with a majority of affected individuals unable to ambulate independently during their lifetime. |
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"
NDD w/hypotonia, facial dysmorphism, brain abnormalities | AR | Hypotonia; Severe DD/ID; Coarse dysmorphic features incl macroglossia; Note: Phenotype is very similar to TBCK-NDD (TBCK PPP1R21 are part of same molecular complex). | Blue sclerae SPTBN4 |
SPTBN4 disorder | AR | Congenital hypotonia; Seizures; Peripheral neuropathy | Auditory neuropathy AR = autosomal recessive; DD = developmental delay; ID = intellectual disability; MOI = mode of inheritance; NDD = neurodevelopmental disorder; TBCK-NDD = TBCK-related neurodevelopmental disorder |
Source: GeneReviews — "TBCK-Related Neurodevelopmental Disorder"